Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.489NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.363NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.95NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.531NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.200NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.299NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.149NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.300NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.179NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.125NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
G.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.438NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.178NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.208NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.197NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.491NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.8 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.631NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.627NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.519NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.514NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.87NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used